# US 2017/0281572 A1 · Formulation for treating chronic wounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0281572 A1
- Document ID: US20170281572A1
- Status: Published application
- Kind: A1
- Application number: 15/508,306
- Filed: 2015-09-02
- Published: 2017-10-05
- Earliest claimed: 2014-09-02
- Assignees: EPIEN Medical, Inc.
- Applicants: EPIEN Medical, Inc.
- Inventors: Michael Basara; Matthew J. Watkins; James Bracke
- Web page: https://patentgrep.com/patent/US20170281572A1

## CPC

- A61K 31/185: Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids (hydroxamic acids A61K31/16; peroxy acids A61K31/327)
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 33/04: Sulfur, selenium or tellurium; Compounds thereof
- A61K 47/02: Inorganic compounds
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 31/04: Antibacterial agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Inventive subject matter disclosed herein includes a method for treating a chronic wound, and methods for treating bacterial infections. The method for treating a chronic wound includes mechanically debriding a chronic wound, and applying a formulation to the wound for 5 to 60 seconds, the formulation including: phenolsulfonic acid—37% by weight; guaiacolsulfonic acid—24% by weight; free sulfuric acid—29% by weight; and water—10% by weight.

## Claims

### Claim at position 1

1-11. (canceled)

### Claim 12

A method of treating a chronic wound, comprising:
applying a formulation to the wound for 5 to 60 seconds, the formulation comprising:
a formulation for treating chronic wounds, comprising:
benzenesulfonic acid in a concentration of 10-75% wt. percent;
phenolsulfonic acid in a concentration of 10-75% wt. percent;
water in a concentration of up to 30% wt. percent; and
colloidal silica in a concentration up to 10% wt. percent.

### Claim 13

A method of treating a chronic wound, comprising:
applying a formulation to the wound for 5 to 60 seconds; the formulation comprising:
phenolsulfonic acid 25-80% by weight;
guaiacolsulfonic acid 25-80% by weight;
ammonium phenol sulfonate 0-5% by weight; and
water 13-30% by weight.

### Claim 14

A method for preventing infections by bacteria, comprising:
applying a formulation comprising phenolsulfonic acid in a concentration of 10-75% by weight;
guiacolfonic acid in a concentration of 10-30% by weight;
free sulfuric acid in a concentration of up to 30% by weight; water in a concentration of up to 0% by weight; and
colloidal silica in a concentration of up to 10% by weight topically to a surface of a living being.

### Claim 15 (depends on 14)

The method of claim 14, wherein the surface of the living being is broken skin.

### Claim 16 (depends on 14)

The method of claim 14, wherein the surface of the living being is bone.

### Claim 17 (depends on 14)

The method of claim 14, wherein the surface of the living being is organ.

### Claim at position 8

18-41. (canceled)

### Claim 42 (depends on 14)

The method of claim 14, wherein the bacteria are antibiotic resistant bacteria.

### Claim 43 (depends on 14)

The method of claim 14, wherein the bacteria are in a persistent state.

### Claim 44 (depends on 14)

The method of claim 14, wherein the bacteria are part of a biofilm.
